VMP 39108911000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-beneldopa 25mg/100mg modified-release capsules
BNF code 0409010K0AAAFAF
Virtual Therapeutic Moiety Co-beneldopa
Date identifier became valid 21 Oct 2020
Previous product identifier 323111002
Basis of preferred name BAN - British Approved Name
Date of name applicability 4 May 2004
Previous name Co-beneldopa 25/100 modified-release capsules
Basis of previous name BAN - British Approved Name
Reason for name change
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Benserazide hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 391821005
Strength value numerator 25.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Levodopa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 100.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsulemodified-release.oral
Dose Form
Formulation Modified-release capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Madopar CR capsules (Roche Products Ltd)
Madopar CR capsules (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Co-beneldopa 25mg/100mg modified-release capsules 100 capsule
Co-beneldopa 25mg/100mg modified-release capsules 30 capsule
Co-beneldopa 25mg/100mg modified-release capsules 60 capsule

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback